NCT02732418 - Lower Dose Depo Provera® Contraceptive Injection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 2, 2016

Primary Completion Date

May 15, 2018

Study Completion Date

May 15, 2018

Conditions

Contraception

Interventions

DRUG

Depo-Provera CI

The active ingredient in Depo-Provera is Medroxyprogesterone acetate (MPA)

DRUG

Depo-subQ 104

The active ingredient in Depo-Provera is Medroxyprogesterone acetate (MPA). Depo-subQ provera 104® (medroxyprogesterone acetate injectable suspension, 104 mg/0.65mL) for subcutaneous injection

Trial Locations (3)

Unknown

Universidade Estadual de Campinas (UNICAMP), Campinas

Instituto Chileno De Medicina Reproductiva (ICMER), Santiago

Asociación Dominicana Pro Bienestar de la Familia, Inc. (PROFAMILIA), Santo Domingo

All Listed Sponsors

lead

FHI 360

OTHER